Chargement en cours...
Outcomes of rituximab therapy in refractory lupus: A meta-analysis
OBJECTIVE: Conventional treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) is associated with damage accrual, hence increased morbidity rate. Off-label use of rituximab (RTX) has shown significant promise in this patient group; however, data are still controversial. We aimed to...
Enregistré dans:
| Publié dans: | Eur J Rheumatol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medical Research and Education Association
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072690/ https://ncbi.nlm.nih.gov/pubmed/30185361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2018.17096 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|